Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000184

Chairperson & CEO sold 7,886 shares at an average $572.69 ($4,516,253)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

25 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-09 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-11-09 Sale : show line 2 in the form 10b5-1 −80 $556.52 $44,522 333,863 I
2026-11-09 Sale : show line 3 in the form 10b5-1 −161 $558.07 $89,849 333,702 I
2026-11-09 Sale : show line 4 in the form 10b5-1 −168 $558.70 $93,862 333,534 I
2026-11-09 Sale : show line 5 in the form 10b5-1 −71 $559.80 $39,746 333,463 I
2026-11-09 Sale : show line 6 in the form 10b5-1 −517 $561.15 $290,114 332,946 I
2026-11-09 Sale : show line 7 in the form 10b5-1 −512 $562.35 $287,923 332,434 I
2026-11-09 Sale : show line 8 in the form 10b5-1 −291 $563.49 $163,976 332,143 I
Open-market sales · 7,886 sh · avg $572.69 · $4,516,253

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-09 Exercise or conversion : show line 26 in the form 10b5-1 Stock Option −9,500 62,410 I
Loading xslF345X06/primarydocument.xml…